A phase 1 study of TS-1 and sorafenib combination therapy in patients with advanced hepatocellular carcinoma.
Phase of Trial: Phase I
Latest Information Update: 30 May 2014
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- 09 Oct 2009 New trial record